GoodRx Holdings Inc (GDRX) reports robust growth in adjusted EBITDA and Pharma Manufacturer Solutions revenue, despite facing ...

GoodRx (NASDAQ: GDRX) Q3 2024 Earnings Call Nov 07, 2024, 8:00 a.m. ET ...

GoodRx (NASDAQ:GDRX – Get Free Report) had its price target lowered by Barclays from $10.00 to $6.00 in a research note ...

On Monday, Goodrx Holdings Inc (GDRX) stock saw a modest uptick, ending the day at $4.89 which represents no change from the prior close of of $4.89. The stock opened at $4.98 and touched a low of $4.

In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on GoodRx Holdings (GDRX – Research Report), ...

Raymond James has recently raised Goodrx Holdings Inc (GDRX) stock to Strong Buy rating, as announced on August 9, 2024, according to Finviz. Earlier, on May 23, 2024, RBC Capital Mkts had raised the ...

Harrow (HROW) stock plunged 20% post-market after the eye care drugmaker’s Q3 earnings report missed Street estimates on the ...

In a report released today, Stephanie Davis from Barclays maintained a Buy rating on GoodRx Holdings (GDRX – Research Report), with a price target of $10.00. The company’s shares closed ...

For the quarter ended September 2024, GoodRx Holdings, Inc. (GDRX) reported revenue of $195.25 million, up 8.5% over the same period last year. EPS came in at $0.08, compared to $0.06 in the year ...